Vaginal misoprostol as effective as dinoprostone pessary for induction of labour,finds study

In a recent development , the noninferiority of 25-μg misoprostol every four hours to the dinoprostone pessary for cesarean delivery (CD) rates after induction of labour (IOL) at term could not be demonstrated, although results from the study highlighted that the confidence limit of the difference barely exceeded the noninferiority margin. Findings have been published in American Journal of Obstetrics & Gynecology.
Induction of labor is among the most common procedures for pregnant women. Only a few randomized clinical trials (RCT) with relatively small samples have compared misoprostol to dinoprostone. Although their efficacy appears similar, their safety profiles have not been adequately evaluated and economic data are sparse.
With this in mind, a team of researchers from Department of Obstetrics and Gynaecology, Paule de Viguier Hospital, France aimed to test the noninferiority of vaginal misoprostol (PGE1) (25 μg) to a slow-release dinoprostone (PGE2) pessary (10 μg) for induction of labor with an unfavorable cervix at term.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.